Midazolam
Midazolam is a pharmaceutical drug with 715 clinical trials. Currently 49 active trials ongoing. Historical success rate of 91.5%.
Success Metrics
Based on 503 completed trials
Phase Distribution
Phase Distribution
338
Early Stage
53
Mid Stage
204
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
87.9%
503 of 572 finished
12.1%
69 ended early
49
trials recruiting
715
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Interaction of BI 425809 With Midazolam, Warfarin, Omeprazole and Digoxin
Evaluation of VX-828 in Healthy Participants and in Participants With Cystic Fibrosis
A Study to Investigate the Safety and PK of VH4770359 in Healthy Participants
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
An Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With Urothelial Cancer
Clinical Trials (715)
Interaction of BI 425809 With Midazolam, Warfarin, Omeprazole and Digoxin
Evaluation of VX-828 in Healthy Participants and in Participants With Cystic Fibrosis
A Study to Investigate the Safety and PK of VH4770359 in Healthy Participants
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
An Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With Urothelial Cancer
A Drug-drug Interaction Study to Evaluate the Effects of Pelabresib on the Pharmacokinetics of Repaglinide, Midazolam, and Combined Oral Contraceptive in Patients With Advanced Malignancies
The Effects of Sedatives on Tobacco Use Disorder Version 2
A Study in Healthy Men to Test Whether BI 425809 Influences the Amount of Midazolam in the Blood
A Study to Assess Drug-drug Interaction of ZX008 in Healthy Male and Female Study Participants
A Study of LY4268989 (MORF-057) in Healthy Participants
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
A Clinical Trial in Healthy Participants to Learn How Itraconazole Affects MK-2828 Levels and How MK-2828 Affects Midazolam Levels (MK-2828-007)
Ketamine for Multiple Sclerosis Fatigue
Safety and Efficacy of Dexmedetomidate vs. Midazolam for Procedural Sedation During Medical Thoracoscopy
A Study to Test How Different Doses of BI 3731579 Are Tolerated by Healthy People
A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specific KRAS Mutation (CodeBreaK 100)
A Study to Test Whether BI 456906 (Survodutide) Influences the Amount of Bupropion, Caffeine and Midazolam in the Blood in People With Overweight or Obesity
An Open-Label Study to Evaluate PF-07994525 in Participants With Advanced Cancers
Prospective IR-led Sedation Feasibility
A Study to Evaluate the Effects of KarXT on the Drug Levels of Midazolam, Fexofenadine, and Digoxin
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 715